Stay updated on Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.

Latest updates to the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has been updated to include new information about a study on gastric cancer, specifically mentioning the drug Capecitabine and the study's revision number. The previous detailed description of the study's purpose and criteria has been removed.SummaryDifference9%
Stay in the know with updates to Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.